| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 146.21B | 150.00B | 148.61B | 140.75B | 133.99B |
| Gross Profit | 15.91B | 17.60B | 17.26B | 15.98B | 14.78B |
| EBITDA | 4.07B | 3.42B | 5.90B | 2.90B | 2.62B |
| Net Income | 3.52B | 3.61B | 3.58B | 3.36B | 3.16B |
Balance Sheet | |||||
| Total Assets | 136.74B | 136.62B | 121.79B | 110.26B | 100.03B |
| Cash, Cash Equivalents and Short-Term Investments | 18.33B | 25.94B | 29.58B | 24.54B | 26.89B |
| Total Debt | 7.48B | 2.03B | 2.38B | 2.46B | 2.38B |
| Total Liabilities | 87.63B | 90.00B | 78.12B | 68.64B | 60.42B |
| Stockholders Equity | 47.86B | 45.44B | 42.58B | 40.36B | 38.41B |
Cash Flow | |||||
| Free Cash Flow | 179.30M | 5.14B | 4.14B | 3.68B | 2.74B |
| Operating Cash Flow | 937.72M | 6.22B | 5.36B | 4.91B | 4.51B |
| Investing Cash Flow | -4.12B | -7.17B | -2.12B | -2.29B | -3.67B |
| Financing Cash Flow | -2.11B | -2.34B | -2.40B | -1.74B | -628.35M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$10.18B | 11.06 | 8.45% | 7.46% | -0.06% | 1.10% | |
70 Outperform | HK$625.38B | 17.94 | 6.83% | 5.40% | 1.29% | -3.41% | |
67 Neutral | HK$170.26B | 11.69 | 6.26% | 4.03% | 2.73% | 8.45% | |
67 Neutral | HK$90.46B | 17.10 | 14.46% | 2.86% | 5.18% | 4.25% | |
64 Neutral | HK$28.40B | 2.36 | 7.60% | 5.24% | 0.06% | -0.05% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
46 Neutral | HK$45.14B | -1,671.68 | -2.39% | 1.68% | 7.18% | 15.72% |